Transgenics can substantially reduce capital investment and lower production costs through economies of scale and more flexible scale-up.
Nancy Markley
Advertisement
Nancy Markley, PhD is director of business development at SemBioSys Genetics Inc.
Articles by Nancy Markley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5